Ataraxis AI Revenue and Competitors
Estimated Revenue & Valuation
- Ataraxis AI's estimated annual revenue is currently $3.6M per year.
- Ataraxis AI's estimated revenue per employee is $155,000
- Ataraxis AI's total funding is $24M.
Employee Data
- Ataraxis AI has 23 Employees.
- Ataraxis AI grew their employee count by 92% last year.
Ataraxis AI's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO & Founder | Reveal Email/Phone |
2 | CEO & Co-Founder | Reveal Email/Phone |
3 | Chief Scientist & Co-Founder | Reveal Email/Phone |
4 | Machine Learning Engineer | Reveal Email/Phone |
5 | Machine Learning Research Engineer | Reveal Email/Phone |
Ataraxis AI Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $7.7M | 31 | 7% | N/A | N/A |
#2 | $288.8M | 1444 | 141% | N/A | N/A |
#3 | $7M | 28 | 47% | N/A | N/A |
#4 | $36M | 118 | -23% | $55M | N/A |
#5 | $1M | 7 | N/A | N/A | N/A |
#6 | $7.9M | 43 | 16% | $458K | N/A |
#7 | $4M | 27 | 350% | $7M | N/A |
#8 | $15.4M | 58 | -16% | $18.3M | N/A |
#9 | $24.9M | 82 | -5% | $20M | N/A |
#10 | $3.6M | 26 | 1200% | $10M | N/A |
What Is Ataraxis AI?
Ataraxis is an AI precision medicine company transforming cancer diagnostics and patient outcomes through the power of AI. We are addressing previously unsolvable problems in cancer prognosis and treatment selection through cutting-edge foundation models and multi-modal data. \n\nOur first clinically validated offering, Ataraxis Breast, is the world’s first AI-native prognostic/predictive test for breast cancer and provides greater accuracy than standard of care genomic assays. To learn more, visit ataraxis.ai.
keywords:N/A
$24M
Total Funding
23
Number of Employees
$3.6M
Revenue (est)
92%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in New York
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $15M | 23 | -4% | N/A |
#2 | $2.1M | 23 | -18% | N/A |
#3 | $2.3M | 23 | -63% | $30M |
#4 | $3.3M | 23 | -23% | N/A |
#5 | $2.3M | 23 | N/A | N/A |